Beijing Key Laboratory of Molecular Pharmaceutics and New Drug Delivery System, Department of Pharmaceutics, School of Pharmaceutical Sciences, Peking University, Beijing, China.
Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Hepato-Pancreato-Biliary Surgery, Sarcoma Center, Peking University Cancer Hospital and Institute, Beijing, China.
CPT Pharmacometrics Syst Pharmacol. 2022 Sep;11(9):1170-1182. doi: 10.1002/psp4.12835. Epub 2022 Jul 4.
Retroperitoneal sarcoma (RPS) is a rare malignancy which can be difficult to manage due to the variety of clinical behaviors. In this study, we aimed to develop a parametric modeling framework to quantify the relationship between postoperative dynamics of several biomarkers and overall/progression-free survival of RPS. One hundred seventy-four patients with RPS who received surgical resection with curative intent at the Peking University Cancer Hospital Sarcoma Center were retrospectively included. Potential prognostic factors were preliminarily identified. Longitudinal analyses of body mass index (BMI), serum total protein (TP), and white blood cells (WBCs) were performed using nonlinear mixed effects models. The impacts of time-varying and time-invariant predictors on survival were investigated by parametric time-to-event (TTE) models. The majority of patients experienced decline in BMI, recovery of TP, as well as transient elevation in WBC counts after surgery, which significantly correlated with survival. An indirect-response model incorporating surgery effect described the fluctuation in percentage BMI. The recovery of TP was captured by a modified Gompertz model, and a semimechanistic model was selected for WBCs. TTE models estimated that the daily cumulative average of predicted BMI and WBC, the seventh-day TP, as well as certain baseline variables, were significant predictors of survival. Model-based simulations were performed to examine the clinical significance of prognostic factors. The current work quantified the individual trajectories of prognostic biomarkers in response to surgery and predicted clinical outcomes, which would constitute an additional strategy for disease monitoring and intervention in postoperative RPS.
腹膜后肉瘤 (RPS) 是一种罕见的恶性肿瘤,由于其临床表现多样,治疗较为困难。本研究旨在建立一种参数建模框架,以量化术后几种生物标志物的动态变化与 RPS 患者总生存(OS)和无进展生存(PFS)之间的关系。本研究回顾性纳入了 174 例在北京肿瘤医院肉瘤中心接受以治愈为目的的手术切除治疗的 RPS 患者。初步确定了潜在的预后因素。采用非线性混合效应模型对体重指数(BMI)、血清总蛋白(TP)和白细胞(WBC)进行纵向分析。通过参数时间事件(TTE)模型研究时变和时不变预测因子对生存的影响。大多数患者在手术后经历 BMI 下降、TP 恢复和 WBC 计数短暂升高,这些变化与生存显著相关。一个纳入手术效应的间接反应模型描述了 BMI 百分比的波动。TP 的恢复由修正的 Gompertz 模型描述,而 WBC 则采用半机械模型。TTE 模型估计预测 BMI 和 WBC 的日累积平均值、第 7 天 TP 以及某些基线变量是生存的显著预测因子。进行了基于模型的模拟以检查预后因素的临床意义。本研究量化了手术对预后生物标志物的个体反应轨迹,并预测了临床结局,这将为术后 RPS 的疾病监测和干预提供另一种策略。